vedolizumab trough levels at week 6 and 14 correlate with clinical remission in inflammatory bowel disease patients

被引：0
|
作者：
Marino, M. [1 ]
Domenis, R. [2 ]
Biribin, L. [1 ]
Cifu, A. [2 ]
Navarria, L. [1 ]
Scardino, G. [1 ]
Fabris, M. [2 ]
机构：
[1] Azienda Sanit Univ Integrata Udine, Dept Gastroenterol, Udine, Italy
[2] Azienda Sanit Univ Integrata Udine, Ist Patol Clin, Udine, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P588
引用
收藏
页码：S492 / S492
页数：1
相关论文
共 50 条
  • [21] VEDOLIZUMAB TROUGH LEVELS AND ANTIBODIES IN INFLAMMATORY BOWEL DISEASE: UPDATED INITIAL EXPERIENCE
    Al-Bawardy, Badr
    Ramos, Guilherme Piovezani
    Willrich, Maria Alice V.
    Park, Sang
    Raffals, Laura
    Tremaine, William J.
    Loftus, Edward V., Jr.
    GASTROENTEROLOGY, 2018, 154 (01) : S89 - S89
  • [22] Role of vedolizumab trough levels in predicting clinical response in Inflammatory Bowel Disease: a multicentre prospective study
    Falzone, M. H.
    Ribaldone, D. G.
    Saracco, G. M.
    Bertani, L.
    Ceccarelli, L.
    Costa, F.
    Bottari, A.
    Fornaroli, G.
    Cusato, J.
    D'Avolio, A.
    Palermiti, A.
    Antonucci, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1216 - I1216
  • [23] Vedolizumab levels during induction are associated with long-term clinical and endoscopic remission in patients with inflammatory bowel disease
    Yarur, A.
    Bruss, A.
    Fox, C.
    Beniwal-Patel, P.
    Patel, A.
    Berens, B.
    Naik, S.
    Stein, D.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S64 - S65
  • [24] VEDOLIZUMAB LEVELS DURING INDUCTION ARE ASSOCIATED WITH LONG-TERM CLINICAL AND ENDOSCOPIC REMISSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Yarur, Andres J.
    Bruss, Alexandra
    Berens, Brandon
    Fox, Caroline
    Beniwal-Patel, Poonam M.
    Patel, Amir
    Ungaro, Ryan C.
    Dubinsky, Marla
    Naik, Snehal
    Stein, Daniel J.
    GASTROENTEROLOGY, 2018, 154 (06) : S827 - S828
  • [25] Early vedolizumab trough levels at induction in inflammatory bowel disease patients with treatment failure during maintenance
    Liefferinckx, Claire
    Minsart, Charlotte
    Cremer, Anneline
    Amininejad, Leila
    Tafciu, Vjola
    Quertinmont, Eric
    Tops, Sophie
    Deviere, Jacques
    Gils, Ann
    van Gossum, Andre
    Franchimont, Denis
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (04) : 478 - 485
  • [26] Early vedolizumab trough levels are not associated with a short-term response in patients with inflammatory bowel disease
    Pudilova, K.
    Kolar, M.
    Duricova, D.
    Malickova, K.
    Hruba, V.
    Machkova, N.
    Vanickova, R.
    Mitrova, K.
    Lukas, M.
    Vasatko, M.
    Lukas, M.
    Bortlik, M.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S356 - S356
  • [27] EARLY VEDOLIZUMAB TROUGH LEVELS ARE NOT ASSOCIATED WITH A SHORT-TERM RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Pudilova, Karolina
    Duricova, Dana
    Kolar, Martin
    Malickova, Karin
    Hruba, Veronika
    Machkova, Nadezda
    Vanickova, Radka
    Mitrova, Katarina
    Lukas, Martin
    Vasatko, Martin
    Lukas, Milan
    Bortlik, Martin
    GASTROENTEROLOGY, 2019, 156 (06) : S877 - S877
  • [28] Week 2 Adalimumab Levels Predict Short-term Clinical Remission in Patients With Inflammatory Bowel Disease
    Buffone, Elisa
    Gupta, Shaan
    Al Ibrahim, Bashaar
    Marshall, John K.
    Halder, Smita
    Tse, Frances
    Albashir, Siwar
    Morgan, David
    Lumb, Barry
    Armstrong, David
    Narula, Neeraj
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2022, 56 (09) : 794 - 797
  • [29] Concentrations of 6-Thioguanine Nucleotide Correlate With Trough Levels of Infliximab in Patients With Inflammatory Bowel Disease on Combination Therapy
    Yarur, Andres J.
    Kubiliun, Maddie J.
    Czul, Frank
    Sussman, Daniel A.
    Quintero, Maria A.
    Jain, Anjali
    Drake, Katherine A.
    Hauenstein, Scott I.
    Lockton, Steven
    Deshpande, Amar R.
    Barkin, Jamie S.
    Singh, Sharat
    Abreu, Maria T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (06) : 1118 - +
  • [30] Vedolizumab Levels During Induction Are Associated With Remission in Patients With Inflammatory Bowel Diseases
    Yarur, Andres
    Bruss, Alexandra
    Patel, Amir
    Beniwal-Patel, Poonam
    Fox, Caroline
    Ungaro, Ryan
    Dubinsky, Marla C.
    Naik, Snehal
    Stein, Daniel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S353 - S354
12345